• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗补体因子 I 抗体相关非典型溶血尿毒症综合征——未来展望的新视角!

Anti-complement factor I antibody associated atypical hemolytic uremic syndrome - A new insight for future perspective!

机构信息

Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.

Division of Allergy and Immunology, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.

出版信息

Immunobiology. 2020 Sep;225(5):152000. doi: 10.1016/j.imbio.2020.152000. Epub 2020 Aug 11.

DOI:10.1016/j.imbio.2020.152000
PMID:32962820
Abstract

Atypical hemolytic uremic syndrome (aHUS) is caused mainly by complement dysregulation. Although various defects in the complement system explaining pathophysiology have been described in recent years, the etiology still remains unclear in about thirty percent of cases. In exploring other causes, similar to anti- complement factor H (anti-CFH) antibody associated HUS, we hypothesized that anti-complement factor I (anti-CFI) antibody could play a role in aHUS. Further, we tried to describe the clinical profile and outcome of those with high anti CFI antibody titers. Eleven of thirty five children (31 %) diagnosed with aHUS from July 2017 to December 2018 had high IgG anti-CFI antibody titers. Median age was 10 months (6, 33) with no sex difference. Thirty-six percent (4/11) had nephrotic-range proteinuria. C3 was low in 8 children (72.7 %) with mean C3 (68.1 ± 14.7 mg/dL). Plasmapheresis was done in 2 children who promptly responded, suggesting the possible role of anti-CFI antibody in pathogenesis of aHUS in these patients. Further studies examining role of anti-CFI antibodies in aHUS is warranted with longitudinal and genetic studies.

摘要

非典型溶血尿毒症综合征 (aHUS) 主要由补体失调引起。尽管近年来描述了许多补体系统缺陷解释其病理生理学的情况,但仍有约 30%的病例病因不明。在探索其他原因时,类似于抗补体因子 H (anti-CFH) 抗体相关的 HUS,我们假设抗补体因子 I (anti-CFI) 抗体可能在 aHUS 中起作用。此外,我们试图描述具有高抗 CFI 抗体滴度的患者的临床特征和结局。2017 年 7 月至 2018 年 12 月,我们诊断了 35 名儿童中的 11 名(31%)患有 aHUS,他们的 IgG 抗 CFI 抗体滴度较高。中位年龄为 10 个月(6,33),无性别差异。36%(4/11)有肾病范围蛋白尿。8 名儿童(72.7%)的 C3 降低,平均 C3(68.1±14.7mg/dL)。2 名儿童接受了血浆置换治疗,反应迅速,提示抗 CFI 抗体可能在这些患者的 aHUS 发病机制中起作用。需要进一步研究抗 CFI 抗体在 aHUS 中的作用,包括进行纵向和遗传研究。

相似文献

1
Anti-complement factor I antibody associated atypical hemolytic uremic syndrome - A new insight for future perspective!抗补体因子 I 抗体相关非典型溶血尿毒症综合征——未来展望的新视角!
Immunobiology. 2020 Sep;225(5):152000. doi: 10.1016/j.imbio.2020.152000. Epub 2020 Aug 11.
2
Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征患者中抗 CFH 自身抗体的免疫特征和功能分析。
Pediatr Nephrol. 2019 Feb;34(2):269-281. doi: 10.1007/s00467-018-4074-4. Epub 2018 Oct 12.
3
Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.感染诱导及补体介导的溶血性尿毒症综合征中的血清学及基因补体改变
Pediatr Nephrol. 2017 Feb;32(2):297-309. doi: 10.1007/s00467-016-3496-0. Epub 2016 Oct 7.
4
Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.产后伴有肾脏受累的非典型溶血尿毒综合征患者补体替代途径的过度激活。
Am J Reprod Immunol. 2015 Oct;74(4):345-56. doi: 10.1111/aji.12404. Epub 2015 May 24.
5
Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.补体基因罕见功能变体与抗 FH 自身抗体相关的 aHUS。
Front Immunol. 2019 May 1;10:853. doi: 10.3389/fimmu.2019.00853. eCollection 2019.
6
Pericardial effusion in anti-complement factor H antibody-associated atypical hemolytic uremic syndrome: two case reports.抗补体因子 H 抗体相关性非典型溶血尿毒症综合征中的心包积液:两例报告。
CEN Case Rep. 2021 May;10(2):255-260. doi: 10.1007/s13730-020-00555-w. Epub 2021 Jan 1.
7
Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.儿童非典型溶血尿毒综合征的临床和遗传学特征:一项中国队列研究。
Nephron. 2021;145(4):415-427. doi: 10.1159/000513009. Epub 2021 Apr 19.
8
Atypical hemolytic uremic syndrome.非典型溶血尿毒综合征。
Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60.
9
Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.C3肾小球病和非典型溶血尿毒综合征中的抗凝血因子H自身抗体:一个靶点,两种疾病。
J Immunol. 2015 Jun 1;194(11):5129-38. doi: 10.4049/jimmunol.1402770. Epub 2015 Apr 27.
10
Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome.补体因子 I 罕见变异 p.Ile357Met 热点与溶血尿毒综合征患者相关。
Am J Kidney Dis. 2024 Aug;84(2):244-249. doi: 10.1053/j.ajkd.2023.12.021. Epub 2024 Feb 28.

引用本文的文献

1
Anti-factor B antibodies in atypical hemolytic uremic syndrome.抗因子 B 抗体在非典型溶血尿毒综合征中的作用。
Pediatr Nephrol. 2024 Jun;39(6):1909-1916. doi: 10.1007/s00467-024-06284-x. Epub 2024 Jan 22.
2
Systematic review of atypical hemolytic uremic syndrome biomarkers.非典型溶血尿毒综合征生物标志物的系统评价
Pediatr Nephrol. 2022 Jul;37(7):1479-1493. doi: 10.1007/s00467-022-05451-2. Epub 2022 Feb 3.
3
Pediatric Atypical Hemolytic Uremic Syndrome Advances.儿科非典型溶血尿毒综合征的研究进展。
Cells. 2021 Dec 18;10(12):3580. doi: 10.3390/cells10123580.